Ensign Group, Inc (ENSG) stock
ENSGNasdaqServices-Skilled Nursing Care FacilitiesFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 27, 2026Score 20/3017% above fair value
$188.23−0.18 (-0.10%)
Close on Nov 16, 2026Market cap $10.98BP/E 28.0Yield 0.13%
Ensign EPS
Diluted earnings per share is net income divided by the share count including options and convertible securities.
Ensign's EPS for the twelve months ending Sep 30, 2026 was $6.72, up 20.2% year over year. For fiscal 2025 it was $5.84, up 14.1% from the year before. Over ten years it grew 18.6% a year on average. The highest annual figure on record is $5.84 in fiscal 2025.
Annual eps
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.84 | +14.1% |
| FY2024 | Dec 31, 2024 | $5.12 | +40.3% |
| FY2023 | Dec 31, 2023 | $3.65 | -7.6% |
| FY2022 | Dec 31, 2022 | $3.95 | +15.5% |
| FY2021 | Dec 31, 2021 | $3.42 | +11.8% |
| FY2020 | Dec 31, 2020 | $3.06 | +55.3% |
| FY2019 | Dec 31, 2019 | $1.97 | +15.9% |
| FY2018 | Dec 31, 2018 | $1.70 | +120.8% |
| FY2017 | Dec 31, 2017 | $0.77 | -19.8% |
| FY2016 | Dec 31, 2016 | $0.96 | -9.4% |
| FY2015 | Dec 31, 2015 | $1.06 | +35.9% |
| FY2014 | Dec 31, 2014 | $0.78 | +44.4% |
| FY2013 | Dec 31, 2013 | $0.54 | -41.6% |
| FY2012 | Dec 31, 2012 | $0.93 | -16.3% |
| FY2011 | Dec 31, 2011 | $1.10 | +15.1% |
| FY2010 | Dec 31, 2010 | $0.96 | +23.9% |
| FY2009 | Dec 31, 2009 | $0.78 | – |
Quarterly eps
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | $1.76 | +23.9% |
| Q2 FY2026 | Jun 30, 2026 | $1.68 | +16.7% |
| Q1 FY2026 | Mar 31, 2026 | $1.67 | +21.9% |
| Q4 FY2025 | Dec 31, 2025 | $1.61 | +18.4% |
| Q3 FY2025 | Sep 30, 2025 | $1.42 | +6.0% |
| Q2 FY2025 | Jun 30, 2025 | $1.44 | +18.0% |
| Q1 FY2025 | Mar 31, 2025 | $1.37 | +15.1% |
| Q4 FY2024 | Dec 31, 2024 | $1.36 | +257.9% |
| Q3 FY2024 | Sep 30, 2024 | $1.34 | +20.7% |
| Q2 FY2024 | Jun 30, 2024 | $1.22 | +8.9% |
| Q1 FY2024 | Mar 31, 2024 | $1.19 | +13.3% |
| Q4 FY2023 | Dec 31, 2023 | $0.38 | -64.2% |
| Q3 FY2023 | Sep 30, 2023 | $1.11 | +12.1% |
| Q2 FY2023 | Jun 30, 2023 | $1.12 | +10.9% |
| Q1 FY2023 | Mar 31, 2023 | $1.05 | +18.0% |
| Q4 FY2022 | Dec 31, 2022 | $1.06 | +23.3% |
| Q3 FY2022 | Sep 30, 2022 | $0.99 | +19.3% |
| Q2 FY2022 | Jun 30, 2022 | $1.01 | +16.1% |
| Q1 FY2022 | Mar 31, 2022 | $0.89 | +3.5% |
| Q4 FY2021 | Dec 31, 2021 | $0.86 | +4.9% |
| Q3 FY2021 | Sep 30, 2021 | $0.83 | +7.8% |
| Q2 FY2021 | Jun 30, 2021 | $0.87 | +19.2% |
| Q1 FY2021 | Mar 31, 2021 | $0.86 | +17.8% |
| Q4 FY2020 | Dec 31, 2020 | $0.82 | +67.3% |
| Q3 FY2020 | Sep 30, 2020 | $0.77 | +60.4% |
| Q2 FY2020 | Jun 30, 2020 | $0.73 | +43.1% |
| Q1 FY2020 | Mar 31, 2020 | $0.73 | +49.0% |
| Q4 FY2019 | Dec 31, 2019 | $0.49 | +2.1% |
| Q3 FY2019 | Sep 30, 2019 | $0.48 | +26.3% |
| Q2 FY2019 | Jun 30, 2019 | $0.51 | +24.4% |
| Q1 FY2019 | Mar 31, 2019 | $0.49 | +14.0% |
| Q4 FY2018 | Dec 31, 2018 | $0.48 | +128.6% |
| Q3 FY2018 | Sep 30, 2018 | $0.38 | +40.7% |
| Q2 FY2018 | Jun 30, 2018 | $0.41 | +78.3% |
| Q1 FY2018 | Mar 31, 2018 | $0.43 | +760.0% |
| Q4 FY2017 | Dec 31, 2017 | $0.21 | -40.0% |
| Q3 FY2017 | Sep 30, 2017 | $0.27 | – |
| Q2 FY2017 | Jun 30, 2017 | $0.23 | – |
| Q1 FY2017 | Mar 31, 2017 | $0.05 | – |
| Q4 FY2016 | Dec 31, 2016 | $0.35 | – |
- Revenue
- Gross Profit
- Operating Income
- Net Income
- EBITDA
- Free Cash Flow
- Operating Cash Flow
- R&D Expenses
- Gross Margin
- Operating Margin
- Profit Margin
- Total Debt
- Cash
- Total Assets
- Shares Outstanding
- Market Cap
- Enterprise Value
- PE Ratio
- Price to Sales Ratio
- Price to Book Ratio
- EV/EBITDA
- Price to Free Cash Flow
- All statistics
See a number that looks wrong?